Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies.

Ca2+ channels SARS-CoV-2 calcium therapeutics viral infections

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
12 01 2022
Historique:
received: 11 12 2021
revised: 05 01 2022
accepted: 11 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 2 2 2022
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). This respiratory illness was declared a pandemic by the world health organization (WHO) in March 2020, just a few weeks after being described for the first time. Since then, global research effort has considerably increased humanity's knowledge about both viruses and disease. It has also spawned several vaccines that have proven to be key tools in attenuating the spread of the pandemic and severity of COVID-19. However, with vaccine-related skepticism being on the rise, as well as breakthrough infections in the vaccinated population and the threat of a complete immune escape variant, alternative strategies in the fight against SARS-CoV-2 are urgently required. Calcium signals have long been known to play an essential role in infection with diverse viruses and thus constitute a promising avenue for further research on therapeutic strategies. In this review, we introduce the pivotal role of calcium signaling in viral infection cascades. Based on this, we discuss prospective calcium-related treatment targets and strategies for the cure of COVID-19 that exploit viral dependence on calcium signals.

Identifiants

pubmed: 35053369
pii: cells11020253
doi: 10.3390/cells11020253
pmc: PMC8773957
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : FWF Austrian Science Fund
ID : P32075-B
Organisme : FWF Austrian Science Fund
ID : P32947
Organisme : FWF Austrian Science Fund
ID : W1250 NanoCell

Références

Lancet. 2021 Dec 11;398(10317):2186-2192
pubmed: 34793741
Gastroenterology. 2015 Aug;149(2):481-92.e7
pubmed: 25917787
Nat Rev Drug Discov. 2019 May;18(5):339-357
pubmed: 30728472
J Virol. 2017 Oct 13;91(21):
pubmed: 28814523
Cancers (Basel). 2020 Oct 06;12(10):
pubmed: 33036292
Aging (Albany NY). 2020 Nov 22;12(22):22425-22444
pubmed: 33221759
ACS Infect Dis. 2021 Oct 8;7(10):2807-2815
pubmed: 34498840
Front Immunol. 2020 Dec 01;11:607069
pubmed: 33335532
Cureus. 2020 May 12;12(5):e8069
pubmed: 32411566
Antiviral Res. 2015 Feb;114:1-10
pubmed: 25451075
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
PLoS One. 2017 Feb 10;12(2):e0171681
pubmed: 28187208
Endocrine. 2020 Dec;70(3):463-464
pubmed: 33094473
Cell Death Differ. 2021 Feb;28(2):626-639
pubmed: 33479399
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Front Med (Lausanne). 2020 Sep 11;7:564170
pubmed: 33043037
Protein Cell. 2022 Sep;13(9):689-693
pubmed: 34687004
mBio. 2018 Jan 30;9(1):
pubmed: 29382735
J Immunol. 2012 Feb 1;188(3):1523-33
pubmed: 22190180
Cell Calcium. 2018 Sep;74:147-159
pubmed: 30075400
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Int J Mol Sci. 2020 May 28;21(11):
pubmed: 32481620
Int J Mol Sci. 2021 Jan 05;22(1):
pubmed: 33466526
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Pharmacol Rev. 2015 Oct;67(4):821-70
pubmed: 26362469
Nat Struct Mol Biol. 2021 Sep;28(9):740-746
pubmed: 34381216
J Immunol. 2009 Mar 15;182(6):3390-7
pubmed: 19265116
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Nat Immunol. 2019 Feb;20(2):152-162
pubmed: 30643259
Channels (Austin). 2013 Sep-Oct;7(5):402-14
pubmed: 23807116
J Cell Physiol. 2015 Sep;230(9):2019-31
pubmed: 25820299
J Biol Chem. 2021 Jul;297(1):100770
pubmed: 33989635
J Med Virol. 2021 Oct;93(10):5825-5832
pubmed: 34061377
J Clin Invest. 2014 Oct;124(10):4549-63
pubmed: 25157823
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Cells. 2019 Dec 30;9(1):
pubmed: 31905994
J Biol Chem. 2009 Aug 7;284(32):21696-706
pubmed: 19506081
Cell. 2007 Dec 14;131(6):1047-58
pubmed: 18083096
Nature. 2006 Nov 9;444(7116):208-12
pubmed: 17093448
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
J Immunol. 2022 Jan 1;208(1):74-84
pubmed: 34819389
Int J Mol Sci. 2020 Dec 31;22(1):
pubmed: 33396497
Science. 2009 Jan 23;323(5913):502-5
pubmed: 19164748
Acta Pharmacol Sin. 2003 Oct;24(10):1051-9
pubmed: 14531951
Arch Virol. 1984;81(1-2):163-70
pubmed: 6743023
Biochem Biophys Res Commun. 2021 Jan 29;538:80-87
pubmed: 33303190
Virology. 2015 Nov;485:330-9
pubmed: 26331680
J Allergy Clin Immunol. 2009 Dec;124(6):1311-1318.e7
pubmed: 20004786
J Physiol. 2019 Jun;597(12):3085-3105
pubmed: 31050811
Annu Rev Virol. 2015 Nov;2(1):473-96
pubmed: 26958925
J Mol Biol. 2021 May 14;433(10):166946
pubmed: 33744314
Nat Rev Immunol. 2012 Jan 20;12(2):136-48
pubmed: 22266691
Adv Ther. 2020 Nov;37(11):4481-4490
pubmed: 32965654
Trials. 2021 Sep 15;22(1):618
pubmed: 34526081
Stud Health Technol Inform. 2021 Nov 18;287:165-166
pubmed: 34795104
Nat Rev Mol Cell Biol. 2012 Sep;13(9):549-65
pubmed: 22914293
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
ACS Infect Dis. 2020 Feb 14;6(2):250-260
pubmed: 31746195
Curr Neuropharmacol. 2018 Jan 30;16(2):137-150
pubmed: 28440188
Mol Aspects Med. 2021 Oct;81:101004
pubmed: 34304899
N Engl J Med. 2020 Aug 6;383(6):517-525
pubmed: 32492293
Handb Exp Pharmacol. 2014;223:1119-42
pubmed: 24961983
EMBO Rep. 2011 Oct 28;12(11):1182-8
pubmed: 21941299
Nature. 1992 Jan 23;355(6358):353-6
pubmed: 1309940
Cell Calcium. 2021 Mar;94:102360
pubmed: 33516131
Nature. 2006 May 11;441(7090):179-85
pubmed: 16582901
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0115521
pubmed: 34310217
Science. 2006 May 26;312(5777):1220-3
pubmed: 16645049
Front Immunol. 2020 Jul 10;11:1708
pubmed: 32754163
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11282-7
pubmed: 22733741
J Immunol. 1998 Nov 1;161(9):4583-90
pubmed: 9794385
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Immunol Rev. 2010 Jul;236:151-66
pubmed: 20636815
EBioMedicine. 2020 Jun;56:102801
pubmed: 32454408
Nat Rev Immunol. 2012 Nov;12(11):749-61
pubmed: 23080391
J Biol Chem. 2008 Aug 29;283(35):23914-21
pubmed: 18579526
Annu Rev Immunol. 2015;33:291-353
pubmed: 25861976
J Pharm Pharm Sci. 2017;20:48-67
pubmed: 28459656
Chin Med J (Engl). 2021 Jun 16;134(13):1602-1609
pubmed: 34133354
J Cell Physiol. 2015 Jun;230(6):1163-9
pubmed: 25204892
Physiol Rev. 1997 Oct;77(4):901-30
pubmed: 9354808
Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:629-654
pubmed: 32966177
Aging (Albany NY). 2020 May 27;12(10):8760-8765
pubmed: 32463794
Nat Rev Immunol. 2007 Sep;7(9):690-702
pubmed: 17703229
EMBO Rep. 2005 Jan;6(1):28-32
pubmed: 15643448
J Biol Chem. 2006 Nov 24;281(47):35855-62
pubmed: 17020874
Eur J Immunol. 2010 Nov;40(11):3028-42
pubmed: 21061435
Cell Mol Life Sci. 2012 May;69(10):1565-75
pubmed: 22527712
Inflammation. 2016 Jun;39(3):1049-58
pubmed: 27025854
Bioorg Chem. 2021 Nov;116:105272
pubmed: 34474305
Int Arch Allergy Immunol. 2021;182(4):324-338
pubmed: 33567446
J Infect Public Health. 2016 May-Jun;9(3):227-30
pubmed: 27095301
Cell Discov. 2020 Dec 22;6(1):96
pubmed: 33349633
J Med Virol. 2022 Apr;94(4):1294-1299
pubmed: 34796525
Immunity. 2011 Nov 23;35(5):792-805
pubmed: 22118527
J Exp Med. 2021 Apr 5;218(4):
pubmed: 33533916
Inflammopharmacology. 2021 Aug;29(4):1001-1016
pubmed: 34110533
N Engl J Med. 2009 May 7;360(19):1971-80
pubmed: 19420366
Physiol Rev. 2015 Oct;95(4):1383-436
pubmed: 26400989
Nature. 2016 Sep 8;537(7619):191-196
pubmed: 27580036
Endocrine. 2020 Jun;68(3):475-478
pubmed: 32533508
J Clin Invest. 2013 Feb;123(2):887-902
pubmed: 23348743
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Sci Transl Med. 2013 Sep 25;5(204):204ra131
pubmed: 24068738
J Cell Biol. 2016 Apr 11;213(1):65-79
pubmed: 27069021
Cell Stress Chaperones. 2020 Sep;25(5):725-729
pubmed: 32761452
Nat Immunol. 2008 Apr;9(4):432-43
pubmed: 18327260
J Cell Biol. 2005 May 9;169(3):435-45
pubmed: 15866891
Annu Rev Immunol. 2001;19:497-521
pubmed: 11244045
J Immunol. 2006 Oct 1;177(7):4853-60
pubmed: 16982927
Curr Neuropharmacol. 2008 Mar;6(1):79-96
pubmed: 19305789
Annu Rev Immunol. 2010;28:491-533
pubmed: 20307213
Curr Biol. 2005 Jul 12;15(13):1235-41
pubmed: 16005298
J Mol Biol. 2017 Dec 8;429(24):3875-3892
pubmed: 29056462
PLoS Biol. 2020 Feb 10;18(2):e3000626
pubmed: 32040508
Eur J Pharmacol. 2013 Sep 15;716(1-3):61-76
pubmed: 23500195
Anesth Analg. 2021 Apr 1;132(4):930-941
pubmed: 33093359
Biochemistry. 2005 Nov 29;44(47):15544-9
pubmed: 16300403
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9357-62
pubmed: 16751269
J Physiol. 2019 Feb;597(4):997-1021
pubmed: 30015354
J Infect Public Health. 2020 Sep;13(9):1224-1228
pubmed: 32622796
Neurosci Bull. 2011 Jun;27(3):135-42
pubmed: 21614096
J Cell Biol. 2005 May 9;169(3):381-2
pubmed: 15866892
Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29
pubmed: 12838335
Trends Immunol. 2020 Oct;41(10):878-901
pubmed: 32711944
Compr Physiol. 2019 Jun 12;9(3):1249-1277
pubmed: 31187891
Int J Mol Sci. 2021 Oct 26;22(21):
pubmed: 34768945
Front Med (Lausanne). 2020 Jun 09;7:315
pubmed: 32582749
Viruses. 2020 Apr 26;12(5):
pubmed: 32357558
Cold Spring Harb Perspect Biol. 2011 Aug 01;3(8):a003947
pubmed: 21746798
Future Med Chem. 2016 May;8(7):817-32
pubmed: 27149324
Function (Oxf). 2020 Dec 21;2(1):zqaa045
pubmed: 34223171
Sci Rep. 2018 Jul 11;8(1):10425
pubmed: 29992955
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2011-6
pubmed: 18250319
J Neurosci. 2006 May 10;26(19):5109-16
pubmed: 16687502
Crit Care. 2020 Aug 14;24(1):502
pubmed: 32795330
Hypertension. 2020 Sep;76(3):732-741
pubmed: 32654555
Antiviral Res. 2014 Oct;110:94-103
pubmed: 25108173
Am J Cardiovasc Drugs. 2019 Jun;19(3):335-342
pubmed: 30637626
Sci Adv. 2020 Jul 31;6(31):
pubmed: 32937591
Cell Calcium. 2009 Apr;45(4):326-30
pubmed: 19157540
Front Pharmacol. 2020 Nov 09;11:582310
pubmed: 33364957
Drug Des Devel Ther. 2021 May 03;15:1819-1833
pubmed: 33976534
Sci Rep. 2021 Nov 17;11(1):22440
pubmed: 34789826
Front Immunol. 2020 Mar 10;11:195
pubmed: 32210952
Med Drug Discov. 2020 Mar;5:100033
pubmed: 32292906
Can J Microbiol. 2021 Mar;67(3):189-212
pubmed: 33264067
Evol Med Public Health. 2020 Nov 23;9(1):149-156
pubmed: 33732462
Front Immunol. 2017 Jul 04;8:757
pubmed: 28725223
Chem Biol Interact. 2021 Aug 25;345:109567
pubmed: 34166652
J Cell Biol. 2007 Apr 23;177(2):265-75
pubmed: 17452530
Brain Neurosci Adv. 2018 Oct 2;2:
pubmed: 30320224
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Cells. 2018 Dec 10;7(12):
pubmed: 30544747
Nature. 2012 Dec 6;492(7427):123-7
pubmed: 23143333
Cell Calcium. 1986 Feb;7(1):1-12
pubmed: 2420465
Mol Biol Rep. 2014 Mar;41(3):1703-11
pubmed: 24413991
Nat Rev Immunol. 2016 Jul;16(7):407-20
pubmed: 27291964
Circ J. 2010 Mar;74(3):567-71
pubmed: 20118567
Curr Neuropharmacol. 2013 Dec;11(6):606-20
pubmed: 24396337
mBio. 2022 Jan 18;13(1):e0337721
pubmed: 35038906
Nat Rev Immunol. 2012 Jun 15;12(7):532-47
pubmed: 22699833
Am J Physiol Lung Cell Mol Physiol. 2014 Jul 15;307(2):L158-72
pubmed: 24838754
Cell Rep. 2018 Jan 2;22(1):72-83
pubmed: 29298434
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Placenta. 2020 Aug;97:1-5
pubmed: 32501218
J Virol. 2020 Jun 16;94(13):
pubmed: 32295925
Sci Signal. 2019 Nov 19;12(608):
pubmed: 31744929
Pharmacol Rep. 2017 Jun;69(3):542-545
pubmed: 28364693
Front Synaptic Neurosci. 2021 Mar 03;13:634760
pubmed: 33746731
Science. 2020 Dec 4;370(6521):
pubmed: 33060197

Auteurs

Sascha Berlansky (S)

Institute of Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020 Linz, Austria.

Matthias Sallinger (M)

Institute of Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020 Linz, Austria.

Herwig Grabmayr (H)

Institute of Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020 Linz, Austria.

Christina Humer (C)

Institute of Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020 Linz, Austria.

Andreas Bernhard (A)

Institute of Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020 Linz, Austria.

Marc Fahrner (M)

Institute of Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020 Linz, Austria.

Irene Frischauf (I)

Institute of Biophysics, Johannes Kepler University Linz, Gruberstrasse 40, 4020 Linz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH